
| Company | Ticker | Business Description | Underwriters | Offer Date |
|---|---|---|---|---|
| Zenas BioPharma | ZBIO | Phase 3 biotech developing therapies for autoimmune and inflammatory diseases. | Morgan Stanley Jefferies |
09/12/24 |
| Zendesk | ZEN | Provides a SaaS customer service platform primarily to SMBs. | Goldman Morgan Stanley |
05/14/14 |
| Zenkoku Hosho | |
|||
| Zenner Metering | |
|||
| Zenta Group | ZGM | Offers a credit risk analysis platform and distributes fintech products in China. | Cathay Sec. |
09/09/25 |
| Zentalis Pharmaceuticals | ZNTL | Phase 1/2 biotech developing novel small molecule therapies for various cancers. | Morgan Stanley Jefferies |
04/02/20 |
| Zenvia | ZENV | Provides a customer experience communications platform in Latin America. | Goldman Morgan Stanley |
07/21/21 |
Important Disclosures
Renaissance Capital LLC is an SEC-registered investment adviser.
© 2025 Renaissance Capital LLC. All rights reserved.